Table 7 Responsiveness statistics and relative ranking of selected HRQL measures according to change on the external criterion: Global Rating of Change
Global Change Score – Substantial Increase +5,+6,+7 | n | T-Statistic (Rank) | Effect Size (Rank) | Guyatt's Responsiveness Statistic (Rank) | Standardized Response Mean (Rank) | Median Rank |
|---|---|---|---|---|---|---|
EQ5D–US Scoring | 7 | 2.13 (4) | 0.78 (2) | 1.08 (6) | 0.82 (5) | 4.50 |
EQ5D–UK Scoring | 7 | 2.10 (5) | 0.75 (3) | 1.11 (5) | 0.81 (6) | 5.00 |
EQ–VAS | 5 | 1.93 (6) | 0.56 (6) | 1.21 (4) | 0.86 (4) | 5.00 |
KCCQ Overall Summary Score | 7 | 3.03 (1) | 0.65 (4) | 1.82 (1) | 1.14 (1) | 1.00 |
KCCQ Clinical Summary Score | 7 | 2.86 (3) | 0.57 (5) | 1.65 (3) | 1.08 (3) | 3.00 |
RAND12 PCS | 7 | 2.98 (2) | 0.93 (1) | 1.82 (2) | 1.12 (2) | 2.00 |
RAND12 MCS | 7 | -1.31 (7) | -0.40 (7) | -0.64 (7) | -0.50 (7) | 7.00 |
Global Change Score – Moderate Increase +2,+3,+4 |  |  |  |  |  |  |
EQ5D–US Scoring | 53 | 1.37 (4) | 0.13 (5) | 0.15 (7) | 0.17 (4) | 4.50 |
EQ5D–UK Scoring | 53 | 1.23 (5) | 0.13 (6) | 0.16 (5) | 0.15 (5) | 5.00 |
EQ–VAS | 51 | 0.89 (7) | 0.14 (4) | 0.18 (4) | 0.12 (7) | 5.50 |
KCCQ Overall Summary Score | 53 | 2.15 (2) | 0.23 (2) | 0.43 (1) | 0.30 (2) | 2.00 |
KCCQ Clinical Summary Score | 53 | 1.45 (3) | 0.16 (3) | 0.30 (3) | 0.20 (3) | 3.00 |
RAND12 PCS | 53 | 0.93 (6) | 0.09 (7) | 0.16 (6) | 0.13 (6) | 6.00 |
RAND12 MCS | 53 | 2.20 (1) | 0.28 (1) | 0.39 (2) | 0.30 (1) | 1.00 |
Global Change Score – No Change -1,0,+1 |  |  |  |  |  |  |
EQ5D–US Scoring | 206 | 2.94 | 0.17 | 0.23 | 0.23 | - |
EQ5D–UK Scoring | 206 | 3.00 | 0.15 | 0.21 | 0.21 | - |
EQ–VAS | 196 | 1.49 | 0.08 | 0.11 | 0.11 | - |
KCCQ Overall Summary Score | 206 | 2.02 | 0.06 | 0.14 | 0.14 | - |
KCCQ Clinical Summary Score | 206 | 1.80 | 0.06 | 0.13 | 0.13 | - |
RAND12 PCS | 206 | 1.85 | 0.08 | 0.13 | 0.13 | - |
RAND12 MCS | 206 | -0.83 | -0.04 | -0.06 | -0.06 | - |
Global Change Score – Moderate Deterioration -2,-3,-4 |  |  |  |  |  |  |
EQ5D–US Scoring | 30 | -0.31 (6) | -0.07 (6) | -0.08 (6) | -0.09 (6) | 6.00 |
EQ5D–UK Scoring | 30 | -0.29 (7) | -0.05 (7) | -0.05 (7) | -0.05 (7) | 7.00 |
EQ–VAS | 29 | -0.91 (5) | -0.14 (5) | -0.17 (5) | -0.17 (5) | 5.00 |
KCCQ Overall Summary Score | 30 | -3.17 (1) | -0.32 (1) | -0.62 (1) | -0.58 (1) | 1.00 |
KCCQ Clinical Summary Score | 30 | -2.62 (2) | -0.28 (2) | -0.51 (2) | -0.48 (2) | 2.00 |
RAND12 PCS | 30 | -1.59 (3) | -0.21 (4) | -0.26 (4) | -0.29(3) | 3.50 |
RAND12 MCS | 30 | -1.40 (4) | -0.23 (3) | -0.30 (3) | -0.25 (4) | 3.50 |
Global Change Score – Substantial Deterioration -5,-6,-7 |  |  |  |  |  |  |
EQ5D–US Scoring | 2 | -1.00 (4) | -0.16 (5) | -0.23 (6) | -0.60 (6) | 5.50 |
EQ5D–UK Scoring | 2 | -1.00 (4) | -0.15 (6) | -0.26 (5) | -0.71 (4) | 4.50 |
EQ–VAS | 2 | -1.67 (2) | -3.54 (1) | -1.57 (1) | -1.18 (2) | 1.50 |
KCCQ Overall Summary Score | 2 | -4.71 (1) | -0.97 (2) | -0.79 (2) | -3.33 (1) | 1.50 |
KCCQ Clinical Summary Score | 2 | -1.60 (3) | -0.57 (3) | -0.77 (3) | -1.13 (3) | 3.00 |
RAND12 PCS | 2 | 0.47 (7) | 1.07 (7) | 0.23 (7) | 0.33 (7) | 7.00 |
RAND12 MCS | 2 | -1.00 (4) | -0.21 (4) | -0.26 (4) | -0.71 (5) | 4.00 |